Ejaculatory and Orgasmic Dysfunction Registry (Climax Registry)
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Ejaculatory Dysfunction
- Sponsor
- Charitable Union for the Research and Education of Peyronie's Disease
- Enrollment
- 500
- Locations
- 1
- Primary Endpoint
- Primary Objective
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
The goal of this observational study is to evaluate the safety and efficacy of various therapies used to treat ejaculatory and/or orgasmic dysfunctions in men. The objective is to create a large, national registry designed to capture key outcomes for men being treated for ejaculatory and/or orgasmic dysfunction.
Participants will submit questionnaires about their diagnosis and treatment efficacy and multiple time intervals.
Detailed Description
The objective of the current study is to create a large, national registry designed to capture key outcomes for men being treated for ejaculatory and/or orgasmic dysfunction. To accomplish this registry, CURE PD has partnered with the Sexual Medicine Society of North America (SMSNA) to help inform sexual medicine providers of the existence of the study and to help encourage patients to enroll. Subjects meeting criteria will be offered study entry by their local provider who will refer them to an email address to indicate their interest. Participants will then be administered questionnaires at baseline and every 3 months x 1 year, followed by every 6 months x 2 years. Patient partners will also be allowed to enroll and will receive questionnaires on the same schedule (baseline, q3 months x 1 year, q6 months x 2 years).
Investigators
Eligibility Criteria
Inclusion Criteria
- •Men being treated for either ejaculatory and/or orgasmic dysfunction
- •For partners, inclusion is being a sexual partner of a man with ejaculatory and/or orgasmic dysfunction who is receiving treatment
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Primary Objective
Time Frame: 3 years
Report subjective efficacy of therapies used to treat ejaculatory dysfunction. Study participants will have the option of indicating if they had used any treatments to treat ejaculatory disorders. If so, they will then be asked to measure its efficacy at improving their symptoms using a 1-10 scale (10 being very effective).